(Q30410677)

15 October 2017

A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis (English)

1 reference

15 October 2017

0 references

1

1 reference

15 October 2017

Ran D Anbar

2

1 reference

15 October 2017

Michael W Konstan

3

1 reference

15 October 2017

Joan R Jacobs

4

1 reference

15 October 2017

Bert Bakker

5

1 reference

15 October 2017

Barbara Lippe

6

1 reference

15 October 2017

David E Geller

7

1 reference

15 October 2017

8 September 2011

1 reference

15 October 2017

Pediatric Pulmonology

1 reference

15 October 2017

47

1 reference

15 October 2017

3

1 reference

15 October 2017

252-263

1 reference

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Impaired fasting glucose in cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Recombinant Human Growth Hormone in the Treatment of Patients With Cystic Fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Growth hormone: the expansion of available products and indications

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Appetite stimulants in cystic fibrosis: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

BMD and body composition in children and young patients affected by cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Cystic fibrosis since 1938.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Endocrine control of body composition in infancy, childhood, and puberty

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Growth hormone and glucose homeostasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Consensus report on nutrition for pediatric patients with cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

2000 CDC Growth Charts for the United States: methods and development

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Wasting as an independent predictor of mortality in patients with cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Afferent signals regulating food intake

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166490

Proteolysis associated with insulin resistance in cystic fibrosis.

20 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Lean body mass in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Association of body composition and lung function in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Growth hormone decreases protein catabolism in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Anabolic effects of growth hormone treatment in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Pulmonary function between 6 and 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Caloric intake and eating behavior in infants and toddlers with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21546

Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial

21 January 2018

1 reference

12 December 2020

The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis

1 reference

12 December 2020

Stature as a prognostic factor in cystic fibrosis survival

1 reference

12 December 2020

Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial

1 reference

12 December 2020

Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis

1 reference

12 December 2020

Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients

1 reference

12 December 2020

Growth during and 2 years after stopping GH treatment in prepubertal children with idiopathic short stature

1 reference

12 December 2020

Identifiers

DOI

10.1002/PPUL.21546

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

21905270

1 reference